Katie Anderson

Katie brings nearly two decades of editorial experience in business-to-business media. After earning her master’s degree in journalism, she began her career at the personal care R&D trade journal Cosmetics & Toiletries. There, she thrived on the constant flow of knowledge gained from interviewing chemists, regulatory experts, formulators and testing professionals in the field.

After nearly eight years with Cosmetics & Toiletries, Katie pursued her passion for skin physiology and ingredient science as Managing Editor of the professional esthetics brand Skin Inc. That same year, she also took on the role of Conference Director for Face and Body, where she developed and managed the event’s educational programming.

Following an acquisition, Katie was promoted to Editor-in-Chief of five professional media brands: Nailpro, Skin Inc., Beauty Launchpad, Medical Esthetics, and WellSpa 360.

Throughout her 19-year editorial career, Katie has held a variety of roles, but her passion has always been scientific editorial. She is the recipient of a bronze Folio Eddie Award for a single science article. She has frequently contributed her expertise as a guest speaker on industry podcasts, webcasts, conferences and video interviews. A lifelong learner, she enjoys the challenge of translating complex technical content into material that is both accurate and accessible.

Connect with Katie on LinkedIn: https://www.linkedin.com/in/katieanderson121/

ARTICLES BY KATIE ANDERSON

At Base Camp: Lilly's Manufacturing Capacity Journey
2/13/2026

In 2025 alone, Lilly announced plans to build new facilities in Texas, Alabama, Virginia and Pennsylvania in addition to facility expansions in Indiana, Wisconsin and Puerto Rico.
Solving The Top 3 Pharma Packaging/Manufacturing Issues
2/5/2026

Regulatory changes, space/footprint constraints and expanding automation garnered more votes than the other challenges. Let’s explore these challenges, and see how the industry is tackling them as we move into 2026.
Novo's Path To The First GLP-1 Weight Loss Pill
1/23/2026

The race to the finish line for the first oral GLP-1 treatment for weight loss was won on Dec. 22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.
5 FDA Approval Categories In 2025
1/15/2026

With less drugs approved in 2025, it is interesting to see what drugs made it through and if any categories of treatment emerged.
A 2025 Pharma Look Back and Look Forward: Editor Style
1/7/2026

Though I still have a great deal to learn about the pharmaceutical industry, I am surrounded by a warm and incredibly bright cast of editors that I gain knowledge from every day.
Top 7 AI Lessons Learned
12/23/2025

As an icebreaker to start the panel, Teresa Minero from LifeBee asked each presenter to share their top recommendations and major issues to avoid with AI.
An AI Use Case in Pharma Process Optimization
12/18/2025

Recordati Ireland’s production coordinator Ross Fitzgerald took attendees through his team’s AI journey, from identifying the problem to using AI data analytics to find a solution.
It's Copy/Paste In Fleet Management Manufacturing
12/11/2025

Copy and paste may be frowned upon in most work tasks, but not in the case of “fleet management.” In the past few years, Roche and Novo Nordisk collaborated to introduce this concept of applying the copy/paste action to standardized, decentralized facilities.
Leveraging Historical Data To Accelerate Process Understanding
12/5/2025

At the ISPE Annual Meeting & Expo, I had the chance to sit in on a presentation by Philippe Cini, partner for A-Connect, who introduced his data-focused method of process understanding to recognize defects early, make process changes quickly and stay on schedule.
Høeg In, Pazdur Out At The FDA
12/4/2025

What an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.